Research programme: beta lapachone conjugates - ArQuleAlternative Names: PGA-ARQ 501
Latest Information Update: 11 Apr 2011
At a glance
- Originator ArQule
- Mechanism of Action Apoptosis stimulants; E2F1 transcription factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 May 2007 Preclinical trials in Cancer in USA (IV)